# FTSE 100 Rises for Second Day as Bank Stocks Lead and Oil Prices Fall

- URL: https://stocks.freetheai.org/news/ftse-100-rises-for-second-day-as-bank-stocks-lead-and-oil-prices-fall-4dd8af
- Published: 2026-10-12T07:31:04Z
- Category: markets; sentiment: bullish; impact: medium
- Symbols: [MARKET:UKX](https://stocks.freetheai.org/symbols/MARKET-UKX)
- Written by our AI from expert market sources across the web for FreeTheAI Stocks, built by Vibhek Soni
- How write-ups are made: https://stocks.freetheai.org/how-we-write
- Not financial advice: https://stocks.freetheai.org/disclaimer

The UK 100 INDEX (TVC:UKX), tracking the FTSE 100, climbed 0.55% to 10,610 GBP on Monday, extending gains into a second consecutive session after an earlier 1.1% rise. The UK index matched broader European equity markets as falling crude oil prices helped boost overall market sentiment across the region.

Banking shares spearheaded the market advance. HSBC and Standard Chartered both gained nearly 2%, while Lloyds Banking Group and NatWest increased by over 1%. Pharmaceuticals also showed resilience, with AstraZeneca gaining over 0.5% even after announcing that its experimental drug efzimfotase alfa missed statistical significance in a late-stage trial for hypophosphatasia. Management noted the treatment could still pursue regulatory approval. Conversely, energy majors BP and Shell trailed the index as weaker oil prices pressured energy stocks.

Market participants are balancing ongoing geopolitical risks against Middle Eastern oil supply stability and potential ceasefires affecting energy infrastructure. Investors will continue tracking crude price movements, regulatory decisions regarding pharmaceutical pipelines, and broader economic updates to gauge the durability of the current market rally.

## Key points

- The FTSE 100 increased 0.55% to 10,610 GBP on Monday, marking its second straight session of gains.
- Bank shares led the rally, with HSBC and Standard Chartered rising nearly 2%, while Lloyds and NatWest gained over 1%.
- AstraZeneca climbed over 0.5% despite its rare disorder treatment efzimfotase alfa missing its main goal in a late-stage trial.
- Energy producers BP and Shell underperformed the broader index due to declining crude oil prices.

## Questions and answers

### Why did the FTSE 100 go up on Monday?

The FTSE 100 rose 0.55% as banking stocks advanced and falling crude oil prices supported broader European market sentiment. HSBC and Standard Chartered led gains among financial equities.

### How did AstraZeneca stock react to its recent trial results?

AstraZeneca stock gained more than 0.5% despite efzimfotase alfa failing to reach statistical significance in a late-stage trial for hypophosphatasia, as leadership indicated the drug may still seek regulatory approval.

### Why were energy stocks lagging in the UK market?

Energy majors BP and Shell underperformed the broader index because falling crude oil prices weighed on energy sector shares.